Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 08 Mar 2023
India may issue a warning over cough syrup exported by Marion Biotech linked to a death in Uzbekistan.
Read Full NewsMind Moments®, a podcast from NeurologyLive®, brings you an exclusive interview with Sneha Mantri, MD, MS. [LISTEN TIME: 24 minutes]
Inebilizumab is the first CD19-targeted B-cell therapy approved for antiAChR- or antiMuSK antibody–positive generalized myasthenia gravis, providing symptom control with twice-yearly dosing.
Weight-Adjusted Waist Index Can Predict CVD Risk in Cardiovascular Kidney Metabolic Syndrome
1.
high response rate when using a bispecific antibody to treat R/R multiple myeloma.
2.
Imetelstat for MDS-relateret anemia er godkendt af Food and Drug Administrations panel.
3.
New research uncovers link between cancer pathway and blood-retina barrier function
4.
Alternative breast imaging techniques beyond mammography.
5.
FAPI PET/CT enhances the staging of recently discovered breast cancer, according to comparative analysis.
1.
Exploring The Causes and Consequences of Low Transferrin Saturation
2.
Biologic Therapies for Cutaneous Immune-Related Adverse Events in the Era of Immune Checkpoint Inhibitors
3.
What is Red Cell Distribution Width and Why Should You Care?
4.
Uncovering the Hidden Symptoms of Parathyroid Cancer in Women
5.
The importance of understanding normal serum osmolality
1.
International Lung Cancer Congress®
2.
Future NRG Oncology Meeting
3.
Genito-Urinary Oncology Summit 2026
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Virtual Case Study on Deep Vein Thrombosis (DVT) - An Initiative by Hidoc Dr.
2.
Navigating the Complexities of Ph Negative ALL - Part X
3.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part VI
4.
Beyond the Mutation: Addressing the Unmet Needs in ALK-Positive NSCLC
5.
Advances in Classification/ Risk Stratification of Plasma Cell Dyscrasias
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge